Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of September, 2022

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches. In respect of the first tranche, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the first tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on May 27, 2021, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended September 30, 2022, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

September 1, 2022

     76,166        241.09p        247.00p        238.50p  

September 2, 2022

     79,605        250.70p        252.50p        243.00p  

September 5, 2022

     63,930        247.14p        249.50p        244.00p  

September 6, 2022

     78,602        250.52p        252.00p        247.00p  

September 7, 2022

     76,605        248.69p        250.50p        247.50p  

September 8, 2022

     76,523        247.96p        249.50p        245.50p  

September 9, 2022

     73,751        251.04p        254.00p        249.00p  

September 12, 2022

     72,152        250.75p        253.50p        247.00p  

September 13, 2022

     73,665        251.43p        255.00p        244.00p  

September 14, 2022

     68,271        249.86p        253.50p        242.50p  

September 15, 2022

     70,254        251.00p        255.00p        247.00p  

September 16, 2022

     71,408        251.45p        258.00p        243.50p  

September 20, 2022

     109,497        239.39p        253.50p        234.50p  

September 21, 2022

     113,625        225.64p        233.00p        222.00p  

September 22, 2022

     113,372        220.90p        224.00p        211.00p  

September 23, 2022

     112,326        218.38p        224.50p        215.00p  

September 26, 2022

     114,347        216.02p        219.00p        211.00p  

September 27, 2022

     114,909        216.02p        219.00p        211.00p  

September 28, 2022

     73,240        223.42p        230.00p        212.50p  

September 30, 2022

     51,258        236.95p        237.00p        235.50p  

During the month ended September 30, 2022, the Company repurchased an aggregate of 1,683,506 Ordinary Shares. As of September 30, 2022, the Company’s issued share capital was 289,012,903 shares, 6,656,345 of which were held in treasury, resulting in total voting rights in the Company of 282,356,558 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

September 1, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4495558.html

September 2, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4497145.html

September 5, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4498809.html

September 6, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4500457.html

September 7, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4502245.html

September 8, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4503844.html

September 9, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4505454.html

September 12, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4507136.html

September 13, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4508833.html

September 14, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4510471.html

September 15, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4511953.html

September 16, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4513692.html

September 20, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4515899.html

September 21, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4517525.html

September 22, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4518975.html

September 23, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4520489.html

September 26, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4522380.html

September 27, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4524262.html

September 28, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4526043.html

September 30, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4529777.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: October 4, 2022   By:  

/s/ Daphne Zohar

    Name:   Daphne Zohar
    Title:   Chief Executive Officer